Asmanex is an inhaled corticosteroid. Asmanex 220 mcg was approved on March 31, 2005, by the FDA for maintenance treatment of asthma as preventive therapy in patients 12 years of age and older.

NEW YORK (MarketWatch) -- Schering-Plough Corp. lifted 27 cents, or 1.5 percent, to $27.29 in premarket trade Thursday after the U.S. Food & Drug Administration approved the Asmanex Twisthaler 220 ...

The FDA has approved mometasone furoate inhalation powder (Asmanex Twisthaler), alendronate sodium plus cholecalciferol tablets (Fosamax Plus D), and an expanded indication for bortezomib ...

Schering-Plough announced that the FDA has approved Asmanex Twisthaler 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to ...

Asmanex Approved for Asthmatic Children. By ABC News. March 24, 2008, 2:54 AM. Mar. 23 -- TUESDAY, Feb. 5 (HealthDay News) -- Schering-Plough's Asmanex Twisthaler, an inhaled steroid designed to ...

FDA has approved a new inhaler therapy for children with asthma called Asmanex Twisthaler 220 mcg to be taken only once daily .<br><br> The oral ...

ASMANEX, indicated for the ... 110 mcg for children between 4 and 11 years old, and 220 mcg for patients 12 and older. ASMANEX is not a rescue inhaler and should not be used to treat sudden asthma ...

Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in patients 12 years of age and older.

Asmanex Twisthaler 220mcg is already available for the maintenance treatment of asthma as prophylactic therapy in patients ≥12 years of age. For more information call (800) 526-4099 or visit www ...

Asmanex Twisthaler has already been available in the 220mcg dosage strength for asthma maintenance in adults. For more information call (800) 526-4099 or visit www.asmanex.com.